argenx SE

argenx SE Earnings Recaps

ARGX.BR Health Care 1 recap
Next earnings: October 22, 2026 (estimated) · full calendar
Q2 2026 Jul 25, 2026

Shares gained 6.1% following strong revenue growth and expanding market penetration, driven primarily by robust product sales and strategic investments in late-stage pipeline programs.

Key takeaways
  • Q2 product net sales reached $1.5 billion, up 60% year-over-year and 17% quarter-over-quarter.
  • U.S. sales grew 15% quarter-over-quarter, with Japan sales increasing 55%, partly boosted by a one-off $25 million distribution model change.
  • Operating expenses rose by $129 million sequentially to $1 billion, reflecting deliberate investment in R&D and commercialization to support pipeline expansion.
  • Operating profit increased 146% year-over-year to $494 million, with a tax rate of 11%.
  • Cash balance strengthened to $5.2 billion, supporting ongoing capital allocation toward sustained long-term growth.